Closed
SectorHealthcare
16.4 1.17
24h
Min
15.99
Max
16.77
Income | -22M -274M |
---|---|
Sales | -5.4M 2.2M |
Profit margin | -12,622.627 |
Employees | 750 |
EBITDA | -284K -284M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +25.29% upside |
Market Cap | 3.4B 11B |
---|---|
Previous open | 15.23 |
Previous close | 16.4 |
By Acuity
50%
50%
166 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 20.31 USD 25.29%
High 24 USD
Low 16 USD
Based on 8 Wall Street analysts offering 12 month price targets forRoivant Sciences Ltd - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$